Business Wire

Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World’s Need for Medicine

HERTFORDSHIRE, England & PITTSBURGH & NEW YORK--(BUSINESS WIRE)--Mylan N.V. (Nasdaq: MYL) and Pfizer Inc. (NYSE: PFE) today announced a definitive agreement to combine Mylan with Upjohn, Pfizer’s ...
Nasdaq

TB Alliance and Mylan Announce Global Collaboration to Commercialize Investigational Drug Pretomanid as Part of Two Regimens to Treat Tuberculosis (TB)

NEW YORK and HERTFORDSHIRE, England and PITTSBURGH, April 18, 2019 /PRNewswire/ -- Non-profit drug developer, TB Alliance, and pharmaceutical company, Mylan N.V. (NASDAQ: MYL), today announced a ...
Business Wire

Pfizer and Mylan Announce Two Future Viatris Board Members

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Mylan N.V. (NASDAQ: MYL) today announced that Ian Read and James Kilts will join the Viatris board of directors upon completion of the planned ...
FiercePharma

Mylan Proposes To Acquire Perrigo For $205 Per Share

THIS ANNOUNCEMENT IS NOT AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES 2013 AND THERE CAN BE NO CERTAINTY THAT AN OFFER WILL ...
FiercePharma

Mylan and Disney Team Up to Bring New Resources to Life for Families Managing Potentially Life-Threatening Allergies

HERTFORDSHIRE, England and PITTSBURGH – Aug. 12, 2015 – Mylan N.V. (Nasdaq: MYL) is pleased to announce today the launch of new resources featuring Disney content and programming, designed to help ...
FierceBiotech

Mylan to Acquire Pfizer Respiratory Delivery Platform

Includes global rights to generic Advair® Diskus and Seretide® Diskus PITTSBURGH, Nov. 9, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has entered into an agreement with ...
FierceBiotech

Mylan Receives Final FDA Approvals for Generic Versions of Lamictal(R) Tablets and Lamictal(R) CD

PITTSBURGH, Jan. 28 /PRNewswire-FirstCall/ --Mylan Inc. (Nasdaq: MYL) today announced that its subsidiaries Mylan Pharmaceuticals Inc. and Genpharm ULC received final ...
Business Insider

Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection)

HERTFORDSHIRE, England and PITTSBURGH and BENGALURU, India, June 11, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced that the U.S. Food ...